The topics discussed In this article illustrate how molecular biology will have a dramatic Impact on arteriosclerosis research. DNA clones for a small number of relevant proteins have been isolated, and studies are underway in numerous laboratories to extend these initial studies. The techniques of molecular biology will provide major advances in our understanding of numerous proteins directly or indirectly involved in the atherogenlc process. Cloning technology will solve the primary structures of many proteins that can not be purified In quantities sufficient for classical methods of analysis. Studies of regulation will benefit from the availability of DNA probes, the ability to generate site-directed antibodies, and the use of reverse genetics to Identify nucleic acid sequences involved in the regulation of gene expression. Studies of gene structure and genetic polymorphisms will unravel the genetic basis for defects In llpld and lipoprotein metabolism and should provide valuable reagents for clinical screening and diagnosis. The reverse genetics approach will permit the systematic analysis of structure-function relationships at the protein level In a manner not previously possible. Each of these will contribute to our understanding of the atherogenic process and should provide insight into ways of preventing and treating arteriosclerosis. T he purpose of this article is to explore how molecular biology can have an impact on research in the broad field of arteriosclerosis. The past few years have seen the techniques of molecular biology applied to an increasingly wider range of problems directly or indirectly related to arteriosclerosis. The first focus of research in this area has been the isolation and characterization of complementary DNA (cDNA) clones for the major apolipoproteins of the plasma lipoproteins. The apolipoproteins were prime targets for initial studies because they are abundant products of lipoprotein-producing tissues and the amino acid sequences of many of these proteins are known. While the current literature seems filled with cloning papers, we only have scratched the surface
T he purpose of this article is to explore how molecular biology can have an impact on research in the broad field of arteriosclerosis. The past few years have seen the techniques of molecular biology applied to an increasingly wider range of problems directly or indirectly related to arteriosclerosis. The first focus of research in this area has been the isolation and characterization of complementary DNA (cDNA) clones for the major apolipoproteins of the plasma lipoproteins. The apolipoproteins were prime targets for initial studies because they are abundant products of lipoprotein-producing tissues and the amino acid sequences of many of these proteins are known. While the current literature seems filled with cloning papers, we only have scratched the surface in this area. In the very near future, clones for many more proteins of importance to arteriosclerosis will be isolated. In addition to the initial information from cloning experiments regarding protein, mRNA, and gene structure, these studies will form the foundation for the analysis of important macromolecules at a level of understanding not previously available. This is true in terms of structure and structure-function relationships as well as in terms of regulation. Furthermore, it is likely that molecular biology will contribute significantly to the clinical side of arteriosclerosis in diagnostics and ultimately in therapeutics.
The subsequent discussion aims to illustrate the above points by proceeding from present knowledge to the fantasy of what may be in the not-too-distant future. First, as a general introduction, strategies for the isolation of genes will be presented. Second, the most immediate consequence that molecular biology will have on arteriosclerosis research, that is, the unraveling of primary sequences of key proteins, will be considered. Third, molecular genetics, including aspects of gene structure, regulation, genetic polymorphisms, and reverse genetics will be discussed. These topics represent the potential that arteriosclerosis research will realize from the application of the techniques of molecular biology.
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Isolation and Characterization of Genes
As an introduction, it is instructive to consider typical methods for the isolation and characterization of genes. 1 In most cases, the isolation of a gene first requires the isolation of cDNA clones for the messenger RNA (mRNA) of interest. The isolation of a specific cDNA clone involves the construction of an appropriate cDNA library and the identification of the specific cDNA within that library. The mRNA is first purified from a tissue that makes the protein of interest. In the case of the plasma apolipoproteins, liver is an appropriate source of the mRNA. Figure 1 shows a typical scheme 2 for library construction in which cDNA is prepared by priming the reverse transcription of mRNA with oligo deoxythymidylic acid (oligo dT) hybridized to the polyadenylic acid (poly A) at the 3' end of most mRNA molecules. After first-strand synthesis and removal of the template mRNA by alkaline hydrolysis, a second strand of cDNA is synthesized with DNA polymerase. In the example shown, second-strand synthesis is primed by a transient hairpin structure at the 3' end of the cDNA. The double-stranded (ds)cDNA is treated with S1 nuclease to remove the hairpin loop and single-stranded regions at the 5' end of the first strand. The resultant blunt-ended, doublestranded cDNA is tailed with deoxycytidylic acid (dC) residues at the 3' ends via reaction with terminal transferase and dCTP. The dC-tailed cDNA is annealed with vector pBR 322 DNA that has been linearized by restriction endonuclease digestion at the unique Pst I site and tailed with deoxyguanylic (dG) acid residues. As illustrated, the cDNA molecules are incorporated into the vector DNA via base pairing between the oligo dC and the oligo dG tails. After transformation of the host bacterium with this hybrid DNA molecule, the DNA repair systems fill in the gaps and regenerate the Pst I restriction site; this permits researchers to recover the inserted DNA from the vector by Pst I digestion. 3 Another feature of this scheme is that the Pst I site lies within the vector gene encoding resistance to ampicillin. Thus, bacteria transformed with vector molecules containing cDNA inserts will be resistant to tetracycline by virtue of the vector Tc R gene but sensitive to ampicillin, since the cDNA insert has disrupted the Ap R gene.
3
A cDNA library formed as illustrated ( Figure 1 ) or with a variety of alternate strategies generally consists of 10 3 -10 s recombinant DNA molecules, each present in a different bacterium. The frequency with which a specific cDNA clone occurs in the library is approximately proportional to the abundance of the specific mRNA within the mRNA population. Since a typical mammalian cell may contain 2 to 5 x 10 5 mRNA molecules, a very large library must be constructed to ensure the inclusion of low abundance mRNAs that are present in only a few copies per cell. However, a small cDNA library may suffice for the isolation of cDNA clones for high abundance mRNAs.
Once the library is constructed, the specific cDNA clone of interest must be identified. Table 1 lists a number of cDNA clones recently isolated and the strategies used to identify the particular clones. The avian very low density lipoprotein (VLDL) apoprotein (apo) II cDNA clone was the first apolipoprotein clone isolated. 45 In this case, the cDNA was prepared from highly purified apo II mRNA, thereby simplifying the identification of the cDNA clone. The apo II cDNA clone was also identified in unfractionated liver cDNA libraries by hybridization with a kinetically fractionated cDNA probe 6 and by a plus-minus screening procedure. 7 In the latter case, the library was screened in parallel with radiolabeled cDNA prepared to mRNA from livers of estrogen-stimulated chickens (plus probe) and with cDNA prepared to mRNA from livers of nonstimulated chickens (minus probe). Since apo II mRNA is only synthesized in response to estrogen, the double screening with plus and minus probes readily identified cDNA clones corresponding to estrogen-induced mRNAs. Nucleotide sequence analysis confirmed the identity of the apo II clone isolated in this manner. 7 Screening of a cDNA library with a kinetically fractionated cDNA probe was also used to identify putative clones to rat apo A IV. 19 The identity of the apo A IV clone was confirmed by a hybrid selection translation procedure in which the cDNA clone was used to purify the mRNA via hybridization. The purified mRNA was then translated in vitro, and the translation product was identified as apo A IV. Similar schemes involving partial mRNA purification and hybrid selection translation have been used to identify cDNA clones to mouse apo A-l, 12 mouse apo E, 18 and rat apo E 16 mRNAs (Table 1) . Human apo E cDNA clones were identified by screening a cDNA library with a probe prepared from the rat apo E cDNA.' 5 An approach which has proved to be widely applicable is the use of oligonucleotide probes to identify The table shows the amino acid sequence of apo A-l for residues 105-109, the potential codons that could code for each amino acid, the mixed oligonucleotide probe prepared by Breslow et al., 9 and the actual sequence of apo A-l mRNA as determined by Breslow et al. from the apo A-l cDNA. specific cDNAs. When the complete or partial amino acid sequence of a protein is known, sequence regions encoded with minimal redundancy in the genetic code can often be identified, and an appropriate oligonucleotide probe to this region can be chemically synthesized. Table 2 shows an example of this approach used by Breslow et al. 9 to identify apo A-l cDNA clones. The amino acid sequence of reidues 105-109 is encoded by a nucleotide sequence that is redundant at only four positions. A mixed oligonucleotide probe that included both C and T at the redundant positions was prepared, radiolabeled, and used to screen a human liver cDNA library. Although only one of the 16 probes in the mixture is a perfect match to the apo A-l cDNA sequence (Table 2) , the hybridization was sufficiently specific to identify putative apo A-l clones that were confirmed by nucleotide sequence analysis. 9 As shown in Table 1 , this approach has been used to identify cDNA clones to a variety of apolipoproteins for which the complete amino acid sequences were known. This approach has also been used to obtain cDNA clones to the bovine LDL receptor. 26 In this case, oligonucleotide probes were prepared on the basis of a very limited amount of protein sequence data obtained by microsequencing of CNBr fragments. The bovine cDNA subsequently was used to identify a human LDL receptor genomic clone, which in turn was used to isolate the cDNA for the human LDL receptor. 27 The full length cDNA clone defines the entire primary amino acid structure of the human LDL receptor. 27 Limited microsequencing and oligonucleotide synthesis will clearly play a major role in the isolation of cDNA clones to a variety of low abundance proteins which are difficult or impossible to purify in amounts sufficient for classical methods of analysis. Table 1 also lists the identification of a rat apo E clone via immunological screening of an expression library. 1728 In this case, cDNA fragments were cloned into a bacteriophage lambda vector, and protein fragments encoded by the cDNA were expressed under control of a regulated lambda gene. The expressed apo E determinants were detected with an antibody to apo E. Similar schemes for the construction of expression libraries in plasmid vectors have been described. 29 Expression libraries should prove useful for the isolation of cDNA clones to proteins for which high quality polyclonal antibodies are available.
A cDNA clone can serve as a reagent for the identification of DNA sequences within a genomic DNA library. Since the mammalian genome is very large (approximately 3 x 10 9 base pairs), genomic libraries are constructed with large fragments of DNA so that the entire genome is represented in a library of manageable size. This usually involves the use of bacteriophage lambda as a cloning vector since very large DNA fragments can be propagated in this vector. Figure 2 shows a typical scheme 30 in which genomic DNA is partially digested with restriction endonucleases to produce fragments of approximately 20 kilobase pairs (kbp). After methylation to block Eco Rl sites in the DNA and ligation to synthetic Eco Rl linker molecules, the DNA fragments are annealed and ligated to a lambda vector which has cohesive Eco Rl ends. The recombinant DNA molecules are packaged into phage particles and amplified on the appropriate bacterial host.
Since the DNA fragments are 20 kbp and the typical mammalian genome contains 2 to 3 x 10 6 kbp, approximately 3 x 10 s phage particles must be screened to detect a gene present in one copy per genome. For this purpose, phage and host bacteria are plated as a lawn on an agar plate, and the plate is incubated to permit plaques of lysed cells to develop. The phage DNA is transferred to a nitrocellulose filter by placing the filter on the surface of the plate. This filter is then hybridized with a radiolabeled DNA probe prepared from the appropriate cDNA clone, and the radioactive signal is detected by autoradiography. The region of the original plate containing the hybridizing DNA is recovered, and the phage carrying the desired DNA is purified by additional rounds of plating and screening with the cDNA probe.
The initial cDNA clone usually provides the probe for the detection of the gene in a homologous genomic library. However, nucleotide sequence homologies among species are often sufficient to permit the isolation of genes via cross-species hybridization. For example, we have recently isolated the apo E gene from an African green monkey library by using the human apo E cDNA clone prepared by Breslow et al. 13 (S Mungal, GS Shelness, T Newman, and DL Williams, unpublished data). When the protein in question has been highly conserved during evolution, genes may be identified with heterologous probes from species much more divergent than this example.
The isolated gene provides structural information as well as specific probes and reagents for additional studies. Generally, the first order of business is the structural analysis of the gene by restriction endonuclease mapping and nucleotide sequencing. For the list in Table 1 , genes now have been isolated for avian apo II, 3132 human apo A-l 3334 human apo C-III, 24 human apo E, 35 human apo C-ll, 21 human LDL receptor, 27 and Chinese hamster HMG Co A reductase. 36 These genes are at various stages of analysis in a number of laboratories. Nucleotide sequences for the avian apo II gene 37 and the human apo A-l gene 33 -M have been reported. Gene organization will be considered below.
Protein Structure
Primary Sequence
The immediate consequence of the isolation of a cDNA clone is the availability of the amino acid sequence deduced from the nucleotide sequence of the cDNA. Table 3 shows a partial list of proteins that have been or are likely to be the initial targets for cloning studies by investigators interested in arterio-sclerosis. The proteins marked with an asterisk have been sequenced by classical methods of protein chemistry. In these cases, the cDNA clones provide confirmatory data and serve to correct errors in the protein data. In addition, the cDNA will yield the sequence of the protein presegment and the prosegment if these have not been determined by protein sequencing of cell-free translation products. For most of the proteins listed in Table 3 , however, amino acid sequence data is not available, and cDNA clones will be the most direct way to obtain this information when the protein can not easily be purified in amounts sufficient for classical analysis.
Apo B is a good example of an important protein that has baffled and frustrated protein chemists for more than 15 years. Although apo B is present at high concentrations in the blood, is relatively easy to purify, and has been the subject of intensive investigation, very little is known about the structure or sequence of this protein. Much of the difficulty lies in the insolubility of apo B, its tendency to aggregate, and its susceptibility to proteolysis. 38 As a result, even such a fundamental property as the molecular weight of apo B has remained controversial. Several research groups are now attempting to isolate cDNA clones for apo B. Limited amino acid sequence data obtained by one group have been used to construct oligonucleotide probes to identify apo B clones. 39 Several putative apo B clones were identified. An alternative approach is the use of expression libraries that may permit apo B clones to be identified with immunological techniques. In either case, we can anticipate that the structure of this difficult protein will be elucidated by these techniques in the not too distant future.
An example of an important protein for which the amino acid sequence was deduced from the nucleotide sequence is the enzyme 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase. HMG CoA reductase has been the subject of considerable investigation because of its key role in cholesterol biosynthesis and its dramatic regulation. 40 However, HMG CoA reductase is a very low abundance enzyme that has been difficult to purify and characterize. Chin et al. 25 isolated a cDNA clone for HMG CoA reductase from a cDNA library prepared from UT-1 cells, a clone of Chinese hamster ovary cells that overproduces the enzyme and its mRNA. The initial cDNA clone was used to identify additional cDNA 41 and genomic 36 clones that define the entire protein and mRNA sequence and the gene sequence in the region of transcription initiation. Analysis of the derived protein sequence has permitted the formulation of an experimentally testable structural model for the insertion of HMG CoA reductase in the endoplasmic reticulum membrane / 2 Analyses of the mRNA and 5' flanking sequences of the gene have identified sequences potentially important for transcription initiation and the control of gene expression. 36 Thus, considerable new information about the structure and regulation of HMG CoA reductase at both the protein and nucleic acid level has been obtained primarily with the use of recombinant DNA techniques. Considerable progress also has been made in the isolation and analysis of cDNA clones for the bovine and human LDL receptor. 2627 The rapid progress made in elucidating the structures of the LDL receptor and HMG CoA reductase illustrates the potential of molecular biology for the analysis of proteins relevant to arteriosclerosis.
Protein Variants
The availability of cDNA clones permits the analysis of protein variants at a level of understanding not possible with biochemical techniques. Genetic variants have been recognized for apo E, apo A-l, apo A-IV, apo B, and apo C-ll by an analysis of protein charge or immunological properties. 35 Elucidation of the nucleotide sequences of the wild type and variant alleles should explain the basis for the variants and may contribute to our understanding of structurefunction relationships in these proteins.
Apo E provides an interesting example in which variants have been studied at both the protein and nucleic acid levels. It has long been known that apo E exhibits charge heterogeneity upon isoelectricfocusing. 43 High resolution, two-dimensional gel analysis demonstrated six human apo E phenotypes that possibly resulted from three common alleles (e4, e3, and e2) at a single genetic locus. 44 The e3 allele was designated as the wild type because it occurs with the highest frequency. As shown in Table 4 , the three alleles differ by arginine (arg)-cysteine (cys) interchanges at residues 112 (e3 cys) and 158 (e3 arg).
45^7 Subsequent analysis of the nucleotide sequence of the e3 allele showed that the codons for 112 (e3 TGC) and 158 (e3 CGC) could undergo single base changes to account for the amino acid differences in the e2 and e4 alleles. 13 This also was the case with an e2* variant that has cysteine instead of arginine at position 145. Nucleotide sequencing of the e4 allele has confirmed this interpretation. 48 Thus, the charge differences between the alleles have been explained both at the level of the amino acid sequence and at the level of the nucleotide substitutions in the gene. This example of allelic variation also provides structure-function information about the protein since the e2 allele binds poorly to apo B/E receptors or hepatic apo E receptors.
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Arginine 158 appears to reside within the receptor binding domain or to influence receptor interactions at another site on the apo E molecule. The physiological significance is that the e2 allele is strongly associated with Type III hyperlipoproteinemia in which patients show a reduced clearance of remnant particles presumably due to the inefficient interaction of the altered apo E with hepatic receptors.
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Nucleotide sequence analysis of other apo E cDNA clones has provided evidence for additional sites of variation in the gene and in the protein. 35 In some cases, base changes in the DNA are silent, i.e., amino acid substitutions do not result. In other The table shows the amino acids at positions 112 and 158 of the three common apo E alleles as determined by amino acid sequence analysis (see references [45] [46] [47] . The codons specifying these amino acids are given in terms of the DNA bases. The codons for the e3 and E4 alleles have been determined by nucleotide sequence analysis of cDNA or genomic clones (see references 13, 15, 35, 48) , which shows that the amino acid substitution is due to a point mutation. The indicated nucleotide substitution in the E2 allele could account for the arg-cys interchange at residue 158, but the nucleotide sequence of the E2 DNA has not yet been determined. cases, there are amino acid substitutions that do not involve charged residues and would not be detected by isoelectric focusing. The analysis at the nucleotide sequence level is clearly more informative with regard to genetic variation in apo E than is analysis at the protein level. In general, this will be the case for most proteins. In addition, nucleotide sequence analysis is easier and faster than amino acid sequence analysis.
Antibodies to Synthetic Peptldes
Another consequence of the availability of the nucleotide sequence of a cDNA and the derived amino acid sequence is the potential for generating antibodies to defined regions of the protein. It is now well recognized that synthetic peptides can elicit antibodies that react with high frequency with the intact native protein. 53 " 55 Both polyclonal and monoclonal antipeptide antibodies have been studied. As a result, it is possible to engineer antipeptide antibodies as probes for specific regions of the protein. This approach generally involves a hydrophilicity analysis of the protein sequence to select regions most likely to be antigenic. 56 Appropriate oligopeptides are synthesized by established methods and used to elicit antibodies by conventional procedures. Antibodies to a variety of viral antigens have been prepared in this fashion. 53 " 55 Antipeptide antibodies to the LDL receptor have been used to determine the orientation of the receptor in the plasma membrane. 57 Antipeptide antibodies also have been used to analyze the domain structure of HMG CoA reductase. 42 This approach should be applicable to almost any protein for which the sequence is known or can be derived from the cDNA.
Molecular Genetics
Gene Structure and Organization
The DNA sequences encoding most eucaryotic proteins occur in multiple segments or exons which are separated by noncoding DNA segments called introns or intervening sequence DNA. Several strategies may be used to determine the arrangement of exons and introns in the DNA and the organization of exon sequences in the mature messenger RNA (mRNA). The ultimate goal is to obtain the sequence of the gene and the mRNA in order to define the organization at the nucleotide level. Figure 3 shows the organization of the apo II gene as an example. Apo II is a small apolipoprotein of 82 amino acid residues that is synthesized in the avian liver in response to estrogenic hormones. 58 Apo II is secreted from the liver on VLDL particles and functions in the transport of VLDL to the oocyte for egg yolk formation. Mature apo II as found in VLDL is illustrated at the bottom of Figure 3 , while the preapo II polypeptide which includes the 24 amino acid signal peptide is diagrammed above mature apo II 37.59.60 A p o n m RNA of 659 nucleotides includes the 318 nucleotides that code for pre-apo II, a 5' noncoding region of 80 nucleotides, and a 3' noncoding region of 261 nucleotides.
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Also illustrated are the 3' polyadenylic acid track and the 5'cap structure which are not encoded in the DNA. As shown above apo II mRNA, the apo II gene is composed of four exons (I-IV) and three introns (A,B, and C) of the indicated sizes. 37 After synthesis of a primary transcript that includes all exons and introns, the precursor mRNA is processed to remove the intron sequences and splice the exon sequences as illustrated. Note that exon I represents 5' untranslated sequence in the mRNA. Exon II encodes additional 5' untranslated sequence, the start codon for translation, and most of the signal peptide for secretion of apo II. Exon III encodes the remainder of the signal peptide and the amino terminal region of the mature protein. Exon IV encodes the carboxyl region of the protein and the entire 3' noncoding region of the mRNA. The alpha helical regions of apo II believed to be important for lipid interactions 5962 are encoded mainly in exon IV.
It is striking that the overall organization of the avian apo II gene is very similar to the organization of the human apo A-l, apo C-III, and apo E genes. 35 Each gene has a small 5' exon representing 5' untranslated sequence. In each case, the start codon for translation and most of the signal peptide are encoded by exon II, the amino terminal region of the mature protein is encoded by exon III, and the carboxyl region and 3' untranslated region are encoded by exon IV. Similarly, the amino acid sequence regions, which can form an amphipathic helix, are encoded by exon IV. These similarities may indicate a common ancestral gene for avian apo II and the mammalian apolipoproteins.
Gene Regulation
The entire nucleotide sequence of the apo II gene and apo II cDNA have been determined. 37 This information enables researchers to approach problems of gene regulation at both the transcriptional and translational levels. As an example, Figure 4 shows the accumulation of apo II mRNA in the avian liver after the administration of estradiol. Apo II mRNA was measured with a DNA-excess solution hybridization assay employing a single-stranded probe. Apo II mRNA accumulates to a level of 15,000 to 20,000 molecules/cell at which point it represents about 10% of the total liver mRNA. This massive accumulation of apo II mRNA results from estrogenstimulated transcription of the gene and hormone action that stabilizes the mRNA against cytoplasmic degradation.
4 " 6 The stabilization of apo II mRNA presumably involves mRNA sequences in the 5' or 3' untranslated regions. The availability of the nucleotide sequence and the appropriate cDNA clones permits researchers to ask which mRNA sequences are necessary for stabilization. Similarly, at the DNA level they can ask which sequences are required for transcription and hormone regulation.
Recent studies 37 -61 indicate that transcription is initiated at three sites on the apo II gene with different frequencies as illustrated at the top of Figure 3 . The significance of multiple initiation sites and the reason why each site is used with a different frequency are not known. The nucleotide sequence adjacent to the initiation sites includes two potential control sequences (boxed sequences) that are believed to be important as promotor sequences in other genes. 64 Studies are in progress in several laboratories to define the function of these sequences and to identify gene sequences that interact with hormone receptors and are necessary for hormone-regulated expression.
Similar studies with mammalian apolipoprotein genes and a variety of genes relevant to arteriosclerosis are clearly of interest and will be pursued as these genes become available. Problems of interest are likely to include the effects of hormones and metabolic intermediates on the expression of apolipoprotein genes, lipoprotein receptor genes, enzymes such as HMG CoA reductase, and a variety of other enzymes involved in lipid metabolism. Similarly, researchers can view endothelial and smooth muscle cell growth regulation in the arterial wall as problems in gene regulation that can be approached in a similar way. It is thought that platelet-derived growth factor (PDGF) plays a significant role in stimulating smooth muscle cell growth in the atherosclerotic lesion. 65 Recent studies indicate that PDGF is highly homologous to the v-sis oncogene carried by the simian sarcoma virus 6667 and can act in concert with other factors to elicit transformation of fibroblasts. 68 PDGF stimulation of cultured cells also results in the enhanced expression of another oncogene, c-myc. 69 These data suggest that growth stimulation in the arterial lesion may share common pathways and cellular mediators with one type of oncogenesis. One consequence of these findings is a merging of the interests of investigators who work in arteriosclerosis and those who do cancer research. An understanding of key steps in growth regulation at the molecular level will probably reveal potential targets for pharmacological intervention in arteriosclerosis as well as in neoplasia.
Another aspect of gene regulation is the tissuespecific expression of genes that is characteristic of differentiated cells. What factors, for example, determine that apolipoprotein genes will be expressed in the liver and small intestine but not in peripheral tissues? Similarly, the recent finding that apo E is synthesized in peripheral tissues 70 and reticuloendothelial cells 71 as well as in the liver raises the question of how this gene is regulated in different cell types. In recent studies, we have determined that the quantitative expression of the apo E gene in various tissues of the nonhuman primate ranges over at least two orders of magnitude. 72 It is of interest to learn the functional significance of these differences and the mechanisms through which they are established. Similar questions may be asked about a variety of genes that show tissue-specific expression and are relevant to arteriosclerosis.
In addition to the analysis of gene expression in tissues or cell culture, DNA probes may be used as histological reagents to examine in vivo gene expression at the cellular level. Figure 5 shows an example from work by McAllister et al. 73 in which a radiolabeled cDNA for the egg-laying hormone (ELH) of the marine snail Aplysiawas used to identify the neurons that synthesize this hormone. Figure 5 A shows a section through the abdominal ganglion which has been hybridized with 1 2 5 I-CDNA to ELH and exposed by autoradiography. The dark staining of the cell clusters in the upper left and right of the ganglion represents intense hybridization of the probe to ELH mRNA in the bag cell neurons. Figures 5 B and C are higher power magnifications of sections showing that the hybridization is restricted to the bag cells. In Figure 5 C, the localization of grains to the cell cytoplasm is evident. Figure 5 D shows localization of the ELH peptide to the bag cells via immunocytochemical staining with anti-ELH antibody. Note that the immunocytochemical technique identified the protein product of the ELH gene while the in situ hybridization technique identified the mRNA for ELH. Thus, the immunocytochemical approach localized cells that contain the protein, while the hybridization procedure localized cells that synthesize the protein. This distinction may be particularly important when attempting to identify cell types that synthesize proteins normally present in the extracellular fluid or those taken up by cells, as is the case with lipoproteins. Similar approaches could be used to identify, within tissues, cell types that synthesize proteins such as apo E, lipoprotein lipase, or LCAT.
Restriction Fragment Length Polymorphisms
A restriction fragment length polymorphism (RFLP) refers to an altered pattern of gene fragments observed when genomic DNA from different individuals is digested with a restriction endonuclease. Since a restriction endonuclease has a specificity for a defined recognition sequence in the DNA, an altered pattern of cleavage could be due to as simple a change as a point mutation or to a com-A B D Figure 5 . In situ hybridization and immunocytochemistry to localize cells expressing the egg laying hormone (ELH) in Aplysia. A. The abdominal ganglion from an adult animal was dissected, fixed with Bouin's stain, sectioned, and hybridized with an 125 l-labeled DNA probe for ELH mRNA. The bag cells comprise the topmost rounded clusters of neurons on both sides of the ganglion. The photomicrograph shows hybridization to cells in both bag-cell clusters as well as to a single isolated neuron in the upper left center of the ganglion. The hybridization is seen as the darkened areas due to the intense concentration of silver grains on the autoradiograph. x 15. B. Hybridization to a section through a single bag-cell cluster. Neurons are stained with methylene blue, x 58. C. A higher magnification (x 368) of bag-cell neurons after in situ hybridization. The deposition of silver grains over the cytoplasm of nerve cell bodies can be seen. D. Immunohistochemical staining with anti-ELH antibody followed by a second antibody coupled to peroxidase. The ELH-containing cells in the bag-cell cluster show darker staining, x 230. Reprinted with permission from reference 73 (copyright 1983 by the American Association for the Advancement of Science).
plex change such as a deletion, insertion, or rearrangement in the DNA. 74 A typical analysis for RFLP involves digestion of isolated DNA with a specific restriction enzyme, electrophoresis of the DNA fragments on an agarose gel, blotting of the DNA fragments in the gel to nitrocellulose paper by the Southern transfer method, 75 hybridization of the blot with a radiolabeled cDNA or genomic DNA probe, and autoradiography of the blot to detect the gene fragments recognized by the probe. Genetic polymorphisms are useful markers for the classification of specific phenotypes or for genetic linkage studies. In some instances, a polymorphism can be instructive as to the basis for a metabolic disorder. Figure 6 shows an example of an apo A-l gene analysis carried out by Karathanasis et al. 76 using DNA from two patients with a familial deficiency of plasma apo A-l and apo C-lll. The autoradiograph shows that digestion of DNA from a normal individual with the enzyme Eco Rl yields a 13 kbp fragment detected with an apo A-l cDNA probe (Lane A). In contrast, the patients have a 6.5 kbp Eco Rl fragment instead of the 13 kbp fragment, indicating an alteration in the DNA in or near the apo A-l gene (Lanes F and G). Since the patients have only the 6.5 kbp fragment, they must be homozygous for this altered apo A-l allele. Note that the mother (Lane D), father (Lane C), and brother (Lane E) of the patients have both fragments, indicating that they are heterozygous for the normal and mutant alleles. The patients also showed a 0.95 kbp fragment in comparison to the wild type, 2.2 kbp fragment when the DNA was digested with the enzyme Pst I. 76 These data suggested that the altered apo A-l gene might be the basis for the lack of plasma apo A-l, but additional studies were needed to define the mutant gene. probe that were used for the blot in Figure 6 . The mutant apo A-l gene is now known to contain a DNA insertion of 7.5 kbp within exon IV that disrupts production of the apo A-l protein. 35 '" Whereas the normal gene yields an Eco Rl fragment of 13 kbp (fragment R1-R2), the mutant gene yields a fragment of 6.5 kbp (fragment R3-R2) due to the presence of an Eco Rl site in the inserted DNA. Note that the R1-R3 fragment was not detected (Figure 6 , Lanes F and G) because the cDNA probe lies completely to one side of the inserted DNA (Figure 7) . The normal and mutant Pst I fragments that were detected with the cDNA probe are also shown (Figure 7) .
In this example, the altered phenotype is clearly due to the DNA rearrangement detected as a rare RFLP. This is an excellent example of how molecular biology has been used to link a specific genetic lesion with premature coronary artery disease. 7677 Further studies showed that the DNA inserted in the apo A-l gene was derived from the apo C-lll gene which lies adjacent to the apo A-l gene. 35 A common RFLP has been identified in the human apo C-ll gene after digestion with the enzyme Taq I. 78 ' 79 This RFLP was used to show linkage between the apo C-ll and apo E genes 78 ' 79 and to demonstrate linkage between the apo C-ll gene and apo C-ll deficiency. 80 Rees et al. 81 also have detected a polymorphism in the flanking region of the apo A-l gene that was subsequently localized to a single base change in the 3' noncoding region of the adjacent apo C-lll gene. 24 This polymorphism was present at higher frequency in hypertriglyceridemic patients although additional studies are required to confirm this finding. These initial studies of RFLP illustrate the potential of such analysis with genes coding for apolipoproteins and enzymes of lipid metabolism. Large patient populations characterized for disorders of lipid and lipoprotein metabolism are available through various lipid clinics in the United States. The analysis of DNA from these patients will probably yield new information relating specific changes in the DNA to phenotypic changes in lipid metabolism. In some cases this approach may lead to the molecular basis for the defect. In other cases RFLP are likely to provide further subcategorization of lipid disorders on the basis of DNA alterations. Such information may be useful in diagnosis and will provide leads for further research.
RFLP has proven useful in the diagnosis of sickle cell anemia because a specific restriction site polymorphism occurs in the 3' flanking region of the human beta globin gene. 82 Prenatal diagnosis of beta thalassaemias also takes advantage of polymorphisms in the globin gene locus. 83 Recent studies indicate that RFLP may be used for prenatal detection of an altered phenylalanine hydroxylase gene associated with phenylketonuria. 84 In addition to the use of polymorphisms occurring within a restriction enzyme recognition sequence, knowledge of the nucleotide sequence may permit researchers to design specific DNA probes to detect an altered gene. For example, Conner et al. 85 have designed specific oligonucleotide probes that can distinguish the sickle cell beta S allele from the normal beta A allele. One synthetic 19 nucleotide probe formed a perfect hybrid with the sickle cell DNA but did not hybridize at all to the beta A DNA due to a single base mismatch. Thus, it is possible to design probes for the detection of point mutations. One could also design probes to screen for specific insertions or deletions in the DNA. While many of these procedures are now performed in the research laboratory, it is not difficult to envision the extension of such procedures to the clinical testing situation. This potential for arteriosclerosis research should develop rapidly as relevant genes are characterized and as RFLP are identified and related to specific metabolic disorders.
Reverse Genetics
Reverse genetics refers to the process through which a specific DNA sequence is altered in vitro and subsequently expressed in vivo to evaluate the functional signifiance of the alteration. The evaluation of function might be at the nucleic acid level or at the level of the protein product depending upon the particular question being asked. The ability to express a gene that has been mutated at specific sites enables the investigtor to approach structure-function relationships with a level of discrimination not previously possible. The typical approach in such studies is to carry out site-directed mutagenesis on an isolated gene to produce a point mutation, deletion, or insertion in the DNA. The altered DNA is constructed into an expression vector and introduced into an appropriate host cell for expression. The evaluation of the engineered mutation might be performed by monitoring function within the host cell or might require purification of the mutated gene product. Reverse genetics has been used primarily to identify the DNA sequences necessary for transcription, the processing of primary mRNA transcripts, and the regulation of gene expression. However, recent studies have shown the potential of reverse genetics for evaluating structure-function relationships at the protein level.
This approach has been used by Villafranca et al. 86 to examine the role of specific amino acid residues in the catalytic activity of dihydrofolate reductase (DHFR) from Escherichia coli. Site-directed mutagenesis was carried out to systematically change three specific amino acid residues within the 159 residue DHFR polypeptide. The specific residues mutated were selected on the basis of the X-ray crystal structure of DHFR to provide information about the mechanism of catalysis and about the folding of the polypeptide chain. After in vitro mutagenesis, the altered DNA was constructed into a plasmid vector and expressed to high levels in E. coli. Subsequently, DHFR was purified from the E. coli and evaluated for activity. With an efficient plasmid expression vector, up to 8 mg of purified DHFR was obtained from a 1 liter culture, thereby providing sufficient enzyme for studies of catalytic activity and physical properties.
These initial experiments clearly illustrate the potential of this strategy for structure-function studies at the protein level. In the example cited above, the crystal structure of DHFR and a wealth of information about the mechanism of catalysis provided the groundwork for designing mutations and asking very directed questions about the enzyme.
Application of a similar strategy to a far less defined situation has also been highly informative in evaluating the biochemical activities of the human transforming protein, ras p21. In these studies, constructs were made to express the normal cellular ras protein or the oncogenic variant which has a valine substituted for glycine at residue 12 of the polypeptide. 87 Expression of these constructs in E. coli permitted the investigators to compare the biochemical properties of the normal and oncogenic ras proteins in crude extracts of the bacteria. These comparisons showed no differences in the binding of GTP or the autophosphorylation activity of the ras proteins. However, the experiments revealed a previously unknown GTPase activity in the normal ras p21 that was significantly reduced in the oncogenic ras p21, 87 For the proteins listed in Table 1 , similar approaches could be used to define amino acid residues or sequence domains required for fundamental activities such as apolipoprotein interactions with lipoproteins, enzyme substrate interactions, or the association of ligands such as apo E or growth factors with their receptors. In the case of apo E, analyses of variant proteins and chemically modified proteins have identified a polypeptide domain involved in binding to the apo B/E and the hepatic apo E receptor. 45 ' 464988 Site-directed mutagenesis should prove useful in extending the analysis of this domain as well as in evaluating other regions of the apo E polypeptide.
Another application of reverse genetics at the protein level is in studies of intracellular protein metabolism. By expressing a mutant protein in a mammalian host cell, one could address questions relating to protein biosynthesis, intracellular protein topogenesis, protein turnover, or the assembly of macromolecular complexes. For example, apo A-1 is synthesized with a 6 amino acid terminal prosegment that is not cleaved until after the protein is secreted. Expression experiments with mutant apo A-1 constructs in liver cell cultures could be carried out to determine whether the prosegment plays a role in the intracellular transport or secretion of apo A-1.
Similarly, expression experiments could be used to examine the polypeptide regions responsible for the plasma membrane localization of lipoprotein receptors or the endoplasmic reticulum localization of HMG CoA reductase. Previously, problems of this nature could only be approached by correlating biochemical changes with amino acid sequence alterations in naturally occurring variants. The development of procedures for site-directed mutagenesis and in vivo expression systems now permits researchers to ask directly how specific mutations influence biochemical function. This is a powerful experimental tool that will permit investigators to examine structure-function relationships at the protein level in a systematic way.
